81227 Cyp2c9 gene com variants
Pathology & Lab
Also known as: CYP2C9 pharmacogenetic panel, CYP2C9 variant testing
Molecular analysis of the CYP2C9 gene to identify common pharmacogenetic variants affecting warfarin metabolism and dosing requirements.
Clinical Context
Used to guide warfarin dosing and monitoring by identifying patients who are CYP2C9 poor metabolizers requiring dose adjustments.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.